Showing 49 - 51 of 51 results
Previous| 1... 3 | 4 | 5 |Next
FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park.
Next Generation Armored Car T-Cell Therapy Trial Now Open
Clinical Trial Takes Aim at Promising Target in Advanced Gastric, Pancreatic Cancers
BROADCASTMED